Since patients who have recovered from SARS-Cov2 show abnormal protein folding and aggregation, the infection may lead to brain degeneration decades after recovery. By following up with patients affected by COVID-19 and recording their neurological deficits, we may detect plausible connections between COVID-19 and risk of developing aging-associated and neurodegenerative disorders such as Parkinson’s disease.